Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51,654,406
-
Total 13F shares
-
5,197,423
-
Share change
-
-1,302,138
-
Total reported value
-
$52,632,000
-
Price per share
-
$10.14
-
Number of holders
-
31
-
Value change
-
-$3,663,646
-
Number of buys
-
19
-
Number of sells
-
12
Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q4 2020
As of 31 Dec 2020 DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) had 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 5,197,423 shares of stock of the company.
Largest 10 holders included Stonepine Capital Management, LLC, Corriente Advisors, LLC, Point72 Asset Management, L.P., Manatuck Hill Partners, LLC, Granite Point Capital Management, L.P., Ikarian Capital, LLC, JACOB ASSET MANAGEMENT OF NEW YORK LLC, NORTHERN TRUST CORP, RENAISSANCE TECHNOLOGIES LLC, and EAM Investors, LLC.
This table shows 33 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.